Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-24 4:11 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 03-Jun-24 | Private Sale (Planned) | 3,250 | $460.00 | $1,495,000.00 | (6%) 50.39K to 47.14K | |
| 30-May-24 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 28-May-24 | Private Sale (Planned) | 3,250 | $454.79 | $1,478,070.00 | (6%) 53.64K to 50.39K | |
| 27-Feb-24 5:08 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 3,309 | $431.79 | $1,428,790.00 | (6%) 56.89K to 53.58K | |
| 21-Feb-24 4:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 2,812 | $420.58 | $1,182,670.00 | (5%) 59.7K to 56.89K | |
| 21-Feb-24 4:49 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Feb-24 | Payment of Exercise | 3,750 | $424.01 | $1,590,040.00 | (6%) 63.45K to 59.7K | |
| 13-Feb-24 5:34 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 2,607 | $422.74 | $1,102,080.00 | (4%) 66.06K to 63.45K | |
| 08-Feb-24 4:47 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 7,114 | -- | -- | 12% 58.95K to 66.06K | |
| 08-Feb-24 4:47 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 15,254 | -- | -- | 35% 43.69K to 58.95K | |
| 04-Jan-24 4:17 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Jan-24 | Private Sale (Planned) | 3,000 | $405.00 | $1,215,000.00 | (6%) 46.69K to 43.69K | |
| 21-Nov-23 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Nov-23 | Private Sale (Planned) | 3,000 | $349.88 | $1,049,640.00 | (6%) 49.69K to 46.69K | |
| 28-Mar-23 4:13 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Mar-23 | Private Sale (Planned) | 1,768 | $305.38 | $539,912.00 | (3%) 51.38K to 49.61K | |
| 21-Mar-23 4:21 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Mar-23 | Private Sale (Planned) | 2,000 | $296.39 | $592,786.00 | (4%) 53.38K to 51.38K | |
| 14-Mar-23 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Mar-23 | Sale (Planned) | 2,666 | $293.83 | $783,346.00 | (5%) 56.05K to 53.38K | |
| 14-Mar-23 4:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Mar-23 | Private Sale (Planned) | 2,088 | $289.61 | $604,709.00 | (4%) 58.13K to 56.05K | |
| 28-Feb-23 5:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 3,308 | $289.12 | $956,409.00 | (5%) 61.44K to 58.13K | |
| 22-Feb-23 4:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-23 | Payment of Exercise | 3,750 | $292.85 | $1,098,190.00 | (6%) 65.19K to 61.44K | |
| 14-Feb-23 5:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 4,992 | $298.26 | $1,488,910.00 | (7%) 70.18K to 65.19K | |
| 14-Feb-23 5:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-23 | Payment of Exercise | 2,707 | $294.33 | $796,751.00 | (4%) 72.89K to 70.18K | |
| 03-Feb-23 5:03 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 30,026 | -- | -- | 70% 42.86K to 72.89K | |
| 04-May-22 5:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-May-22 | Private Sale (Planned) | 343 | $258.83 | $88,778.20 | (< 1%) 43.07K to 42.73K | |
| 03-May-22 4:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-Apr-22 | Payment of Exercise | 547 | $276.17 | $151,065.00 | (1%) 43.62K to 43.07K | |
| 05-Apr-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Apr-22 | Private Sale (Planned) | 2,582 | $264.76 | $683,602.00 | (6%) 46.2K to 43.62K | |
| 21-Mar-22 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Mar-22 | Private Sale (Planned) | 3,171 | $250.15 | $793,218.00 | (6%) 49.37K to 46.2K | |
| 28-Feb-22 5:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-22 | Payment of Exercise | 2,189 | $227.86 | $498,786.00 | (4%) 51.56K to 49.37K | |
| 22-Feb-22 5:04 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 3,439 | $232.51 | $799,602.00 | (6%) 55.0K to 51.56K | |
| 14-Feb-22 10:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-22 | Payment of Exercise | 2,434 | $237.74 | $578,659.00 | (4%) 57.44K to 55.0K | |
| 03-Feb-22 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-22 | Sale (Planned) | 2,944 | $250.07 | $736,206.00 | (5%) 60.38K to 57.44K | |
| 03-Feb-22 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 25,588 | -- | -- | 74% 34.79K to 60.38K | |
| 05-May-21 9:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Apr-21 | Payment of Exercise | 547 | $217.21 | $118,814.00 | (2%) 35.23K to 34.68K | |
| 26-Feb-21 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-21 | Payment of Exercise | 547 | $217.57 | $119,011.00 | (2%) 35.77K to 35.23K | |
| 12-Feb-21 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 2,365 | $214.16 | $506,488.00 | (6%) 38.14K to 35.77K | |
| 05-Feb-21 5:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 21,951 | -- | -- | 136% 16.19K to 38.14K | |
| 14-Jul-20 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Jul-20 | Private Sale (Planned) | 700 | $293.15 | $205,206.00 | (4%) 16.83K to 16.13K | |
| 01-May-20 4:27 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 30-Apr-20 | Payment of Exercise | 547 | $251.78 | $137,724.00 | (3%) 17.27K to 16.73K | |
| 26-Feb-20 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-20 | Payment of Exercise | 542 | $239.23 | $129,663.00 | (3%) 17.82K to 17.27K | |
| 07-Feb-20 4:30 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-20 | Grant | 14,021 | -- | -- | 369% 3.79K to 17.82K | |
| 12-Apr-19 4:00 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Apr-19 | Grant | 3,697 | -- | -- | 100% 0 to 3.7K | |
| 18-Mar-15 10:37 AM View: | Bruker Corp (BRKR) | 17-Mar-15 | Market Sale | 19,000 | $18.97 | $360,493.00 | (16%) 118.92K to 99.92K | (328%) |
| 04-Sep-14 11:55 AM View: | Bruker Corp (BRKR) | 30-Aug-14 | Payment of Exercise | 3,062 | $20.26 | $62,036.10 | (3%) 121.99K to 118.92K | (301%) |
| 12-Aug-14 3:47 PM View: | Bruker Corp (BRKR) | 08-Aug-14 | Grant | 25,895 | -- | -- | 27% 96.09K to 121.99K | |
| 05-Aug-14 12:58 PM View: | Bruker Corp (BRKR) | 02-Aug-14 | Payment of Exercise | 10,476 | $22.40 | $234,662.00 | (10%) 106.57K to 96.09K | (263%) |
| 04-Sep-13 4:30 PM View: | Bruker Corp (BRKR) | 30-Aug-13 | Grant | 25,726 | -- | -- | 32% 80.84K to 106.57K | |
| 06-Aug-13 1:35 PM View: | Bruker Corp (BRKR) | 02-Aug-13 | Payment of Exercise | 7,186 | $19.93 | $143,217.00 | (8%) 88.03K to 80.84K | (307%) |
| 06-Aug-12 4:03 PM View: | Bruker Corp (BRKR) | 02-Aug-12 | Grant | 88,028 | -- | -- | 100% 0 to 88.03K | |
| 18-Oct-11 4:23 PM View: | Progress Software Corp. (PRGS) | 14-Oct-11 | Grant | 25,000 | $20.73 | $518,250.00 | 45% 56.17K to 81.17K | 106% |
| 04-Oct-11 4:17 PM View: | Progress Software Corp. (PRGS) | 01-Oct-11 | Payment of Exercise | 3,281 | $17.75 | $58,221.30 | (6%) 59.46K to 56.17K | (141%) |
| 02-May-11 4:46 PM View: | Progress Software Corp. (PRGS) | 28-Apr-11 | Grant | 14,000 | $29.64 | $414,960.00 | 31% 45.46K to 59.46K | 44% |
| 05-Apr-11 3:01 PM View: | Progress Software Corp. (PRGS) | 01-Apr-11 | Payment of Exercise | 2,544 | $29.52 | $75,111.60 | (5%) 48.0K to 45.46K | (45%) |
| 16-Jul-10 4:53 PM View: | Millipore Corp. (MIL) | 14-Jul-10 | Disposition | 6,996 | $107.00 | $748,572.00 | (100%) 7.0K to 0 | |
| 17-Feb-10 4:23 PM View: | Millipore Corp. (MIL) | 15-Feb-10 | Payment of Exercise | 1,844 | -- | -- | (21%) 8.84K to 7.0K |